Desvenlafaxine

Actavis Pharma, Inc.🇺🇸 United States

FDA Page

Effective Date: Sep 18, 2025
Approval ID: 617476f9-62d7-40ef-a1b1-c349d4ad706f
Products: 3 registered
Version: 27

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use DESVENLAFAXINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DESVENLAFAXINE EXTENDED-RELEASE TABLETS . DESVENLAFAXINE extended -re lease tablets, for oral use Initial U.S. Approval: 2008

Quick Stats

Total Products3

Labelers1

Label Sections42

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.